Detalles de la búsqueda
1.
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
Am J Hum Genet
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723632
2.
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.
Br J Cancer
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740969
3.
Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses' Health Studies.
Breast Cancer Res Treat
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38592542
4.
Sexually Transmitted Infections and Risk of Epithelial Ovarian Cancer: Results From the Finnish Maternity Cohort.
J Infect Dis
; 228(11): 1621-1629, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37196097
5.
Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort.
Breast Cancer Res
; 25(1): 42, 2023 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37069615
6.
Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
Int J Cancer
; 152(9): 2002-2010, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305647
7.
Profiling the immune landscape in mucinous ovarian carcinoma.
Gynecol Oncol
; 168: 23-31, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368129
8.
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
J Pathol
; 256(4): 388-401, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897700
9.
The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study.
Eur J Epidemiol
; 38(5): 545-557, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988840
10.
Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
BMC Med
; 20(1): 118, 2022 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35430795
11.
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.
Gynecol Oncol
; 164(1): 195-201, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34776242
12.
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Am J Obstet Gynecol
; 226(6): 821.e1-821.e26, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921803
13.
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research.
Carcinogenesis
; 42(6): 785-793, 2021 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34037709
14.
Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies.
Int J Cancer
; 148(11): 2692-2701, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33433939
15.
Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.
BMC Med
; 19(1): 101, 2021 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33926456
16.
Dietary intake of trans fatty acids and breast cancer risk in 9 European countries.
BMC Med
; 19(1): 81, 2021 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33781249
17.
Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study.
Eur J Epidemiol
; 36(8): 827-839, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33331993
18.
Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-ß, and ERß: results from the EPIC-Heidelberg cohort.
Breast Cancer Res
; 22(1): 23, 2020 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32075687
19.
Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort.
Int J Cancer
; 147(5): 1325-1333, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011733
20.
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.
Int J Cancer
; 147(8): 2042-2052, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243586